The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Conditions: Pancreatic Cancer Interventions: Drug: Surufatinib combine immune checkpoint inhibitor; Drug: AG/FOLFIRINOX Sponsors: Luo Cong Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials